
ARGX vs NTES
$ARGX vs $NTES head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ARGX vs NTES: the quick read
- ·NTES is the larger company by market cap ($80.20B vs $51.65B).
- ·ARGX has been more active on our scanner (109 vs 33 alerts in 30 days).
- ·ARGX has the smaller float (61.9M vs 640.3M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Biological Products, (No Diagnostic Substances) vs Services-Prepackaged Software), so they answer to different catalysts and a move in one says little about the other.
- ·NTES trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·ARGX draws far more of our scanner's attention, 109 unusual-volume alerts in 30 days against 33, so it is the more actively traded of the two by some distance.
- ·NTES pays a dividend and ARGX does not, which usually means one is being held for income and the other for the move.
- ·They are pulling apart today: ARGX is outperforming the other by roughly 5.5 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ARGX and NTES on TheDesperateTrader.
- Is ARGX or NTES the better stock?
- "Better" depends on your goal, and these two are not alike. NTES is the larger company by market cap ($80.20B vs $51.65B). ARGX has been more active on our scanner (109 vs 33 alerts in 30 days). ARGX has the smaller float (61.9M vs 640.3M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ARGX and NTES?
- The differences that matter: they are not in the same business - ARGX is biological products, (no diagnostic substances) and NTES is services-prepackaged software; they are similar in size ($51.65B vs $80.20B); they trade at very different share prices ($868.12 vs $124.83); ARGX sits at 50% of its 52-week range against 40% for NTES; only NTES pays a dividend; our scanner flagged ARGX 109 times in the last 30 days against 33 for NTES. Everything above is measured from the latest completed session and SEC filings.
- Which of ARGX and NTES is more active right now?
- Right now ARGX is at about 1.1x its normal volume and NTES is at about 0.5x, so ARGX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ARGX or NTES? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ARGX and NTES comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.